FDA OKs AI Device to Detect Diabetic Retinopathy in Primary Care

The IDx-DR device detects greater than mild diabetic retinopathy without the need for a clinician to interpret the image or results.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply